Enter assignee name

EPO Patents = 2

Trademarks = 1

Forward Citations = 0

Loading Chart...

4 inventors (with patents filed for the assignee):

Sylvain Lengacher (4 out of 5 patents)

Charles Finsterwald (4 out of 4 patents)

Pierre Magistretti (4 out of 4 patents)

4. Timothy John Ritchie (1 out of 18 patents)

5. Pierre Magistretti (0 patent)

4 patents: Sort by Forward Citations

1. 12433892 - Compositions and methods of treatment for neurological disorders comprising depression (2025-10-07),

2. 12310967 - Compositions and methods of treatment for neurological disorders comprising motor neuron diseases (2025-05-27),

3. 12274703 - Compositions and methods of treatment for neurological disorders comprising a dementia (2025-04-14),

4. 11925632 - Isoquinoline derivatives for use in treating GLUT1 deficiency syndrome (2024-03-12),

Gliapharm Sa is a biopharmaceutical company focused on discovering and developing innovative therapies for neuromuscular disorders and other rare diseases. The company leverages advanced molecular technologies to create targeted treatments aimed at addressing the underlying pathological mechanisms of these conditions. With a dedicated team of experts in drug development and a commitment to improving patient outcomes, Gliapharm Sa aims to bring novel therapies from concept to clinical application. Their research initiatives are supported by a collaborative approach, working alongside academic institutions and industry partners to advance scientific knowledge and enhance treatment options for affected patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#69 in Geneva

#1,952 in Switzerland

Geneva, Switzerland

Gliapharm Sa